Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis
- 1 October 2003
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 33 (10), 1380-1388
- https://doi.org/10.1046/j.1365-2222.2003.01786.x
Abstract
Background Cysteinyl leukotrienes (CysLTs) are bioactive lipids that have been shown to contribute to allergic and inflammatory diseases. Eosinophils and mast cells have the capacity to produce...Keywords
This publication has 44 references indexed in Scilit:
- Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fallAnnals of Allergy, Asthma & Immunology, 2002
- The effect of montelukast (MK‐0476), a cysteinyl leukotriene receptor antagonist, on allergen‐induced airway responses and sputum cell counts in asthmaClinical and Experimental Allergy, 1999
- Nasal Immunotherapy in Weed-Induced Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- Comparison of rhinomanometry, symptom score, and inflammatory cell counts in assessing the nasal late-phase reaction to allergen challengeJournal of Allergy and Clinical Immunology, 1994
- Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cellsJournal of Allergy and Clinical Immunology, 1992
- The cellular response of the human allergic mucosa to natural allergen exposureJournal of Allergy and Clinical Immunology, 1988
- Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive childrenJournal of Allergy and Clinical Immunology, 1988
- Allergen‐Induced Release of Sulphidopeptide Leukotrienes (SRS‐A) and LTB4 in Allergic RhinitisAllergy, 1985
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984